Advances and breakthroughs in prostate disease
Reviewed by Per-Anders Abrahamsson, M.D., Ph.D.
Advances in the understanding and treatment of prostate disease are constantly being reported at scientific meetings and in peer-reviewed publications. What follows are some of the most interesting recent findings, placed in context by Per-Anders Abrahamsson, a member of Perspectives' editorial and advisory board and Secretary General of the European Association of Urology, the leading professional organization overseas.
Testosterone seen unrelated to prostate cancer risk
Researchers have long believed that male sex hormones, including testosterone, influence the risk of prostate cancer. However, a collaborative analysis of 18 prospective studies, published in February, determined that they are not associated with prostate cancer risk.